Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Shares Outstanding (Weighted Average) (2020 - 2025)

Core Scientific's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $318.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 24.33% year-over-year to $318.1 million; the TTM value through Dec 2025 reached $318.1 million, up 24.33%, while the annual FY2025 figure was $318.1 million, 24.33% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $318.1 million at Core Scientific, roughly flat from $318.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $379.9 million in Q4 2023 and bottomed at $157.8 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $315.9 million (2025), against an average of $289.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) surged 105.24% in 2022 before it crashed 52.51% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $207.3 million in 2021, then soared by 64.35% to $340.6 million in 2022, then rose by 11.51% to $379.9 million in 2023, then tumbled by 32.65% to $255.8 million in 2024, then increased by 24.33% to $318.1 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Shares Outstanding (Weighted Average) are $318.1 million (Q4 2025), $318.6 million (Q3 2025), and $316.6 million (Q2 2025).